BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29504235)

  • 1. Cytokine profile (IL-2, IL-6, IL-17, IL-22, and TNF-α) in vitiligo-New insight into pathogenesis of disease.
    Sushama S; Dixit N; Gautam RK; Arora P; Khurana A; Anubhuti A
    J Cosmet Dermatol; 2019 Feb; 18(1):337-341. PubMed ID: 29504235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combination of tumour necrosis factor-α -308A and interleukin-10 -1082G gene polymorphisms and increased serum levels of related cytokines: susceptibility to vitiligo.
    Aydıngöz IE; Kanmaz-Özer M; Gedikbaşi A; Vural P; Doğru-Abbasoğlu S; Uysal M
    Clin Exp Dermatol; 2015 Jan; 40(1):71-7. PubMed ID: 25283497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-helper 17 cytokines (interleukins 17, 21, 22, and 6, and tumor necrosis factor-α) in patients with alopecia areata: association with clinical type and severity.
    Atwa MA; Youssef N; Bayoumy NM
    Int J Dermatol; 2016 Jun; 55(6):666-72. PubMed ID: 26235375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T helper and regulatory T cell cytokine profile in active, stable and narrow band ultraviolet B treated generalized vitiligo.
    Tembhre MK; Sharma VK; Sharma A; Chattopadhyay P; Gupta S
    Clin Chim Acta; 2013 Sep; 424():27-32. PubMed ID: 23680073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-33 circulating serum levels are increased in patients with non-segmental generalized vitiligo.
    Vaccaro M; Cicero F; Mannucci C; Calapai G; Spatari G; Barbuzza O; Cannavò SP; Gangemi S
    Arch Dermatol Res; 2016 Sep; 308(7):527-30. PubMed ID: 27388717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of helper and regulatory T cells in the pathogenesis of vitiligo.
    Basak PY; Adiloglu AK; Ceyhan AM; Tas T; Akkaya VB
    J Am Acad Dermatol; 2009 Feb; 60(2):256-60. PubMed ID: 19022528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased interleukin-6 and granulocyte-macrophage colony stimulating factor levels in the sera of patients with non-segmental vitiligo.
    Tu CX; Gu JS; Lin XR
    J Dermatol Sci; 2003 Feb; 31(1):73-8. PubMed ID: 12615367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levels of TNF-α, IL-6, IL-17, IL-37 cytokines in patients with active vitiligo.
    Karagün E; Baysak S
    Aging Male; 2020 Dec; 23(5):1487-1492. PubMed ID: 33191834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of circulating Th1/ Th2/ Th17 cytokines in serum of Chlamydia trachomatis-infected women undergoing incomplete spontaneous abortion.
    Prasad P; Singh N; Das B; Raisuddin S; Dudeja M; Rastogi S
    Microb Pathog; 2017 Sep; 110():152-158. PubMed ID: 28648621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predominant role of innate pro-inflammatory cytokines in vitiligo disease.
    Gholijani N; Yazdani MR; Dastgheib L
    Arch Dermatol Res; 2020 Mar; 312(2):123-131. PubMed ID: 31620869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MIF promotes a differential Th1/Th2/Th17 inflammatory response in human primary cell cultures: Predominance of Th17 cytokine profile in PBMC from healthy subjects and increase of IL-6 and TNF-α in PBMC from active SLE patients.
    De la Cruz-Mosso U; García-Iglesias T; Bucala R; Estrada-García I; González-López L; Cerpa-Cruz S; Parra-Rojas I; Gámez-Nava JI; Pérez-Guerrero EE; Muñoz-Valle JF
    Cell Immunol; 2018 Feb; 324():42-49. PubMed ID: 29397904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
    Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
    Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased circulating Th17 cells and elevated serum levels of TGF-beta and IL-21 are correlated with human non-segmental vitiligo development.
    Zhou L; Shi YL; Li K; Hamzavi I; Gao TW; Huggins RH; Lim HW; Mi QS
    Pigment Cell Melanoma Res; 2015 May; 28(3):324-9. PubMed ID: 25604047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Peculiarities of cytokine status in patients with vitiligo and stress in anamnesis].
    Tsiskarishvili NV; Katsitadze A; Tsiskarishvili NI; Chitanava L
    Georgian Med News; 2014 Oct; (235):45-8. PubMed ID: 25416216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced Th1 and Th17 responses in peripheral blood in active non-segmental vitiligo.
    Zhen Y; Yao L; Zhong S; Song Y; Cui Y; Li S
    Arch Dermatol Res; 2016 Dec; 308(10):703-710. PubMed ID: 27687555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-21 and other serum proinflammatory cytokine levels in patients with multiple myeloma at diagnosis.
    Mehtap O; Atesoglu EB; Tarkun P; Hacihanefioglu A; Dolasik I; Musul MM
    J Postgrad Med; 2014; 60(2):141-4. PubMed ID: 24823512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic immunosuppression by candida in HIV infection: a cytokine based analysis.
    Bajaj JS; Singh A; Aggarwal SK; Chattopadhya D; Baveja UK
    J Commun Dis; 2000 Mar; 32(1):1-9. PubMed ID: 11186879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 17, interleukin 22 and FoxP3 expression in tissue and serum of non-segmental vitiligo: a case- controlled study on eighty-four patients.
    Elela MA; Hegazy RA; Fawzy MM; Rashed LA; Rasheed H
    Eur J Dermatol; 2013; 23(3):350-5. PubMed ID: 23797460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-33 affects cytokine production by keratinocytes in vitiligo.
    Li P; Ma H; Han D; Mou K
    Clin Exp Dermatol; 2015 Mar; 40(2):163-70. PubMed ID: 25251808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th1, Th2, and Th17 Cytokine Involvement in Thyroid Associated Ophthalmopathy.
    Shen J; Li Z; Li W; Ge Y; Xie M; Lv M; Fan Y; Chen Z; Zhao D; Han Y
    Dis Markers; 2015; 2015():609593. PubMed ID: 26089587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.